An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis
- 10 August 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 13 (2) , 125-131
Abstract
Introduction: Ankylosing spondylitis is a chronic immune-mediated disease affecting the sacroiliac joints and the spine manifesting with new bone formation and osteopenia. Over the past decade, tumour necrosis factor alpha (TNF-α) inhibitors (TNFi) have become the cornerstone for therapy in improving functional outcomes, and decreasing disease activity in patients with a marginal benefit from non-steroidal anti-inflammatory (NSAID) therapy. At this time, it remains to be determined whether these agents decrease new bone formation, although some studies have recently suggested that. Areas covered: In this review we discuss the factors that favour a good response to these agents both initially and during maintenance, and some of the more recent studies outlining strategies for dose reduction. Expert commentary: Finally, we discuss the importance of using more objective tools for disease activity, such as magnetic resonance imaging, as a complementary tool for clinical assessments in both predicting responses to treatment but also in selecting patients most suited for targeted therapy.Keywords
Funding Information
- Abbvie, Amgen, Boehringer, Celgene, Eli-Lilly, Janssen, Merck, Pfizer, Sanofi and UCB
This publication has 57 references indexed in Scilit:
- Association of receptor activator of nuclear factor-kappaB ligand (RANKL) gene polymorphisms with the susceptibility to ankylosing spondylitis: a case-control studyJournal of Orthopaedic Science, 2014
- A complex interaction between Wnt signaling and TNF-α in nucleus pulposus cellsArthritis Research & Therapy, 2013
- High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2012
- Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosisAnnals of the Rheumatic Diseases, 2012
- A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitisNature Genetics, 2011
- Increased mortality in ankylosing spondylitis is related to disease activityAnnals of the Rheumatic Diseases, 2011
- Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac jointsAnnals of the Rheumatic Diseases, 2010
- Ankylosing spondylitis: an overviewAnnals of the Rheumatic Diseases, 2002
- TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligandJournal of Clinical Investigation, 2000
- Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisArthritis & Rheumatism, 1995